Board meeting on October 27, 2026 to consider and approve unaudited results for September quarter
Board meeting scheduled for Tuesday, October 27, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Tuesday, October 27, 2026
- Results Period
- quarter ended September 30, 2026 (unaudited, standalone and consolidated)
- Trading Window
- closed from October 01, 2026; shall open 48 hours after the results are disseminated
What the company told the exchanges
The Board of Directors of the company is scheduled to meet on Tuesday, October 27, 2026. The meeting will take up, amongst other matters, the consideration and approval of the unaudited financial results for the quarter ended September 30, 2026. Both standalone and consolidated results are covered.
- Board meeting date: October 27, 2026
- Results to be approved: unaudited standalone and consolidated results for the quarter ended September 30, 2026
- The notice also covers "amongst other matters", so the agenda is not limited to the results
Why this matters to a shareholder
A board meeting notice of this kind marks the date on which the company's quarterly numbers become public. Until the results are out, this update carries no performance information — it is a calendar announcement, not a comment on how the business performed.
Trading window
The company's Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015 required the trading window for Designated Persons to be closed from October 01, 2026 for the quarter ended September 30, 2026. It shall open 48 hours after the financial results are disseminated.
The trading window restriction applies to Designated Persons (insiders) and is a standard pre-results measure. It is separate from the results themselves and does not restrict public shareholders.
What to watch for
- The actual standalone and consolidated results, expected to be considered at the October 27, 2026 meeting
- Any other decisions taken at the meeting, since the notice mentions "amongst other matters" without listing them
How to read this announcement
This is a scheduling and compliance intimation. It tells investors when to expect the September quarter results; it does not by itself indicate whether the quarter was strong or weak. The picture will become clear only when the numbers are approved and published.
Also from Onesource Specialty Pharma
OneSource Specialty Pharma schedules Q2FY27 earnings call for October 27, 2026 at 18:30 IST
21 Oct 2026
More numbers
- Period after results dissemination when trading window shall open48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.